USC Medication Class Description | No Hospitalization (n = 15,457) | Hospitalization Without ICU Admission (n = 2916) | ICU Admission (n = 1185) | ||||||
---|---|---|---|---|---|---|---|---|---|
Baseline Phase, n (%) | Post-Acute Phase, n (%) | Change From Baseline to Post-Acute Phase, Δ (% Change) | Baseline Phase, n (%) | Post-Acute Phase, n (%) | Change From Baseline to Post-Acute Phase, Δ (% Change) | Baseline Phase, n (%) | Post-Acute Phase, n (%) | Change From Baseline to Post-Acute Phase, Δ (% Change) | |
Vitamins | 619 (4.0) | 891 (5.8) | 272 (43.9) | 100 (3.4) | 166 (5.7) | 66 (66.0) | 52 (4.4) | 80 (6.8) | 28 (53.8) |
Miscellaneous preparations | 603 (3.9) | 792 (5.1) | 189 (31.3) | 161 (5.5) | 250 (8.6) | 89 (55.3) | 67 (5.7) | 105 (8.9) | 38 (56.7) |
Blood factors | 499 (3.2) | 627 (4.1) | 128 (25.7) | 134 (4.6) | 185 (6.3) | 51 (38.1) | 42 (3.5) | 76 (6.4) | 34 (81.0) |
Hemostatic modifiers | 1366 (8.8) | 1618 (10.5) | 252 (18.4) | 533 (18.3) | 765 (26.2) | 232 (43.5) | 194 (16.4) | 336 (28.4) | 142 (73.2) |
Nutrients and supplements | 625 (4.0) | 771 (5.0) | 146 (23.4) | 258 (8.8) | 325 (11.1) | 67 (26.0) | 97 (8.2) | 150 (12.7) | 53 (54.6) |
Cardiac agents | 808 (5.2) | 968 (6.3) | 160 (19.8) | 279 (9.6) | 352 (12.1) | 73 (26.2) | 116 (9.8) | 165 (13.9) | 49 (42.2) |
Antineoplastic targeted therapy | 384 (2.5) | 454 (2.9) | 70 (18.2) | 109 (3.7) | 135 (4.6) | 26 (23.9) | 43 (3.6) | 55 (4.6) | 12 (27.9) |
Thyroid therapy | 1722 (11.1) | 1958 (12.7) | 236 (13.7) | 361 (12.4) | 427 (14.6) | 66 (18.3) | 139 (11.7) | 168 (14.2) | 29 (20.9) |
Neurologic/neuromuscular disorders | 2736 (17.7) | 3065 (19.8) | 329 (12.0) | 749 (25.7) | 836 (28.7) | 87 (11.6) | 305 (25.7) | 370 (31.2) | 65 (21.3) |
Gastrointestinal | 3769 (24.4) | 4097 (26.5) | 328 (8.7) | 879 (30.1) | 1015 (34.8) | 136 (15.5) | 354 (29.9) | 483 (40.8) | 129 (36.4) |
Psychotherapeutic drugs | 4697 (30.4) | 5077 (32.8) | 380 (8.1) | 871 (29.9) | 1043 (35.8) | 172 (19.7) | 308 (26.0) | 410 (34.6) | 102 (33.1) |
Diagnostic aids | 2394 (15.5) | 2614 (16.9) | 220 (9.2) | 611 (21.0) | 710 (24.3) | 99 (16.2) | 283 (23.9) | 328 (27.7) | 45 (15.9) |